Skip to main content
Stonvex
Loading…
Home
Activity
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
Log in
Get Started
← Back to rankings
NXTC
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Loading latest news…
52w high -38.1%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
nasdaq
nextcure
clinical
cancer
announced
data
novel
after
trading
rating
nyse
results
class
high
today
last
period
reported
compared
stage
NXTC
NextCure, Inc. Common Stock
Stonvex
StonvexStonvexStonvexStonvex